MPC
70
5
EBAY
52
4
FSLR
34
-9
TAP
31
2
STI
10
2
CAH
53
2
DVA
59
2
BAC
57
3
BXP
17
2
EXC
60
2
MAR
65
3
AMGN
55
-4
ILMN
63
3
RHI
32
4
SE
55
8
UNP
48
2
APA
50
5
CME
58
5
LYB
27
-2
PEP
74
-3
MPC
70
5
EBAY
52
4
FSLR
34
-9
TAP
31
2
STI
10
2
CAH
53
2
DVA
59
2
BAC
57
3
BXP
17
2
EXC
60
2
MAR
65
3
AMGN
55
-4
ILMN
63
3
RHI
32
4
SE
55
8
UNP
48
2
APA
50
5
CME
58
5
LYB
27
-2
PEP
74
-3
Financhill
Back

Nektar Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

NKTR
Nektar Therapeutics

Last Price:
$68.98
Seasonality Move:
2.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Nektar Therapeutics Stock Forecast

  • Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 43.9% based on the past 31 years of stock performance.
  • Nektar Therapeutics has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%
  • Is Nektar Therapeutics Stock Undervalued?
    The current Nektar Therapeutics [NKTR] share price is $65.90. The Score for NKTR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Nektar Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 43.9% based on the past 31 years of stock performance.

Nektar Therapeutics Stock Rating

Buy
55
Nektar Therapeutics (NKTR) is a Buy

Is Nektar Therapeutics overpriced?

  • Nektar Therapeutics has risen higher in 14 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.16%

Nektar Therapeutics Stock Price History

Is NKTR stock going to rise?

  • The current trend is moderately bullish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com

52-Week Data

52-Week High:
75.67
52-Week Low:
6.48

Prediction Charts

Market Cap:
1.1B
Price in USD:
65.90
Volume:
1.4M
Beta:
1.26

Technical Analysis

SMA50:
47.47
SMA100:
52.94
SMA200:
39.79
52-Wk Change:
463.18%

Stock Predictions

  • Is Nektar Therapeutics stock public?
    Yes, Nektar Therapeutics is a publicly traded company.
  • What is the Nektar Therapeutics stock quote today?
    The Nektar Therapeutics stock price is 65.90 USD today.
  • How to buy Nektar Therapeutics stock online?
    You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-6 35.18 36.81 37.26 34.47
Feb-9 36.88 37.07 37.66 35.60
Feb-10 47.15 56.00 56.76 47.05
Feb-11 59.00 66.35 67.94 58.95
Feb-12 63.33 71.00 72.31 62.00
Feb-13 70.48 71.33 73.37 67.70
Feb-17 71.44 73.82 74.89 69.85
Feb-18 73.50 73.18 74.87 71.31
Feb-19 73.30 73.86 74.84 71.72
Feb-20 73.99 73.73 74.83 71.50
Feb-23 73.50 73.62 75.67 70.66
Feb-24 73.88 68.42 73.88 68.20
Feb-25 68.35 70.37 71.94 68.35
Feb-26 70.00 65.90 70.99 64.50

Nektar Therapeutics Earnings

Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Nektar Therapeutics Forecast Revenue Growth

Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $2.76 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.36 per share, and a decrease next year of $2.17 per share.

* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.